End-of-day quote
Shanghai S.E.
23:00:00 06/06/2024 BST
|
5-day change
|
1st Jan Change
|
26.26
CNY
|
+2.94%
|
|
-4.61%
|
-39.04%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,745
|
3,703
|
11,131
|
6,593
|
4,302
|
2,628
|
-
|
-
|
Enterprise Value (EV)
1 |
2,745
|
3,703
|
11,131
|
6,593
|
4,302
|
2,628
|
2,628
|
2,628
|
P/E ratio
|
24.6
x
|
29.1
x
|
40.6
x
|
33.2
x
|
30.1
x
|
14.1
x
|
7.7
x
|
9.79
x
|
Yield
|
-
|
1.09%
|
0.78%
|
0.9%
|
1.16%
|
3.36%
|
4.28%
|
-
|
Capitalization / Revenue
|
6.76
x
|
8.2
x
|
12.7
x
|
7.72
x
|
4.42
x
|
2.34
x
|
1.64
x
|
1.92
x
|
EV / Revenue
|
6.76
x
|
8.2
x
|
12.7
x
|
7.72
x
|
4.42
x
|
2.34
x
|
1.64
x
|
1.92
x
|
EV / EBITDA
|
-
|
21.8
x
|
33.2
x
|
24.6
x
|
18.3
x
|
8.19
x
|
6.38
x
|
5.51
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.8
x
|
9.09
x
|
4.26
x
|
2.6
x
|
1.37
x
|
1.2
x
|
1.15
x
|
Nbr of stocks (in thousands)
|
97,138
|
97,138
|
97,430
|
99,876
|
99,876
|
100,058
|
-
|
-
|
Reference price
2 |
28.26
|
38.12
|
114.2
|
66.01
|
43.07
|
26.26
|
26.26
|
26.26
|
Announcement Date
|
24/02/20
|
17/02/21
|
25/02/22
|
14/02/23
|
24/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
406
|
451.6
|
877.6
|
853.8
|
972.2
|
1,123
|
1,601
|
1,371
|
EBITDA
1 |
-
|
169.9
|
335.7
|
268.5
|
234.8
|
321
|
412
|
477
|
EBIT
1 |
-
|
147.1
|
303.3
|
223.9
|
176.2
|
211
|
382.5
|
305
|
Operating Margin
|
-
|
32.58%
|
34.55%
|
26.23%
|
18.13%
|
18.78%
|
23.89%
|
22.25%
|
Earnings before Tax (EBT)
1 |
-
|
148.3
|
317.8
|
215.7
|
174.7
|
211
|
381.1
|
305
|
Net income
1 |
-
|
127.4
|
275.4
|
197.9
|
153
|
186
|
340.7
|
268.2
|
Net margin
|
-
|
28.21%
|
31.38%
|
23.17%
|
15.74%
|
16.56%
|
21.28%
|
19.56%
|
EPS
2 |
1.149
|
1.310
|
2.815
|
1.988
|
1.433
|
1.858
|
3.412
|
2.683
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.4167
|
0.8928
|
0.5952
|
0.5000
|
0.8833
|
1.125
|
-
|
Announcement Date
|
24/02/20
|
17/02/21
|
25/02/22
|
14/02/23
|
24/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
13.9%
|
24.2%
|
13.9%
|
9.06%
|
15.4%
|
17.4%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
10.9%
|
19.2%
|
10.1%
|
5.87%
|
6.3%
|
7.3%
|
8%
|
Assets
1 |
-
|
1,170
|
1,432
|
1,951
|
2,608
|
2,953
|
4,667
|
3,352
|
Book Value Per Share
2 |
-
|
10.00
|
12.60
|
15.50
|
16.50
|
19.10
|
21.90
|
22.90
|
Cash Flow per Share
2 |
-
|
1.310
|
3.960
|
-0.3300
|
-0.9800
|
2.830
|
4.360
|
-
|
Capex
1 |
-
|
95.2
|
286
|
184
|
104
|
250
|
306
|
300
|
Capex / Sales
|
-
|
21.09%
|
32.6%
|
21.5%
|
10.68%
|
22.25%
|
19.09%
|
21.89%
|
Announcement Date
|
24/02/20
|
17/02/21
|
25/02/22
|
14/02/23
|
24/02/24
|
-
|
-
|
-
|
Last Close Price
26.26
CNY Average target price
31.67
CNY Spread / Average Target +20.59% Consensus |
1st Jan change
|
Capi.
|
---|
| -39.04% | 363M | | -8.74% | 60.98B | | +65.24% | 46.1B | | +14.54% | 38.12B | | +0.50% | 31.12B | | +7.38% | 19.32B | | +10.83% | 16.52B | | +7.90% | 13.8B | | -5.22% | 12.96B | | -23.61% | 12.44B |
Other Commodity Chemicals
|